Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology (Q35673265)

9 August 2017

1 reference

3 April 2019

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology (English)

1 reference

9 August 2017

1 reference

3 April 2019

1 reference

1 reference

Steven Joniau

6

0 references

Silvio Monfardini

object named as

Silvio Monfardini

8

0 references

Mark Emberton

4

object named as

Mark Emberton

1 reference

9 August 2017

12

Fred Saad

1 reference

9 August 2017

13

Cora N Sternberg

1 reference

9 August 2017

Jean-Pierre Droz

1

1 reference

9 August 2017

Lodovico Balducci

2

1 reference

9 August 2017

Michel Bolla

3

1 reference

9 August 2017

John M Fitzpatrick

5

1 reference

9 August 2017

Michael W Kattan

7

1 reference

9 August 2017

Judd W Moul

9

1 reference

9 August 2017

Arash Naeim

10

1 reference

9 August 2017

Hendrik van Poppel

11

1 reference

9 August 2017

language of work or name

1 reference

25 March 2010

1 reference

9 August 2017

1 August 2010

1 reference

3 April 2019

2 references

9 August 2017

3 April 2019

106

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

462-469

1 reference

Creative Commons Attribution 2.5 Generic

9 August 2017

copyright license

1 reference

on focus list of Wikimedia project

3 April 2019

ScienceSource

0 references

cites work

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Management of metastatic prostate cancer: the crucial role of geriatric assessment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

12 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Guideline for the management of clinically localized prostate cancer: 2007 update.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Estimates of the cancer incidence and mortality in Europe in 2006.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

20-year outcomes following conservative management of clinically localized prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Cancer screening in elderly patients: a framework for individualized decision making

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Measuring comorbidity in older cancer patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Cumulative illness rating scale

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Do older men benefit from curative therapy of localized prostate cancer?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Treatments for prostate cancer in older men: 1984-1997.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3258484

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09334.X

Management of cancer in the older person: a practical approach

21 January 2018

1 reference

12 December 2020

Variations in morbidity after radical prostatectomy

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

A brief clinical instrument to classify frailty in elderly people

1 reference

12 December 2020

Risk of fracture after androgen deprivation for prostate cancer

1 reference

12 December 2020

Predicting life expectancy in men with clinically localized prostate cancer

1 reference

12 December 2020

Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891

1 reference

12 December 2020

Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study

1 reference

12 December 2020

Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer

1 reference

12 December 2020

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

12 December 2020

EAU guidelines on prostate cancer

1 reference

12 December 2020

Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891)

1 reference

12 December 2020

Undernutrition in elderly patients with cancer: Target for diagnosis and intervention

1 reference

12 December 2020

Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras

1 reference

12 December 2020

10.1111/J.1464-410X.2010.09334.X

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference